Eva C Coopmans

Consensus on criteria for acromegaly diagnosis and remission

Andrea Giustina, Nienke R. Biermasz, Felipe F. Casanueva et al. · Pituitary · 2023 · 193 citations · Full text

Medicine, Endocrinology, Internal Medicine +16

T2-signal intensity, SSTR expression, and somatostatin analogs efficacy predict response to pasireotide in acromegaly

Eva C Coopmans, J.J. Schneiders, Nour El-Sayed et al. · European Journal of Endocrinology · 2020 · 61 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Pasireotide Responsiveness in Acromegaly Is Mainly Driven by Somatostatin Receptor Subtype 2 Expression

Ammar Muhammad, Eva C Coopmans, Federico Gatto et al. · The Journal of Clinical Endocrinology & Metabolism · 2018 · 60 citations · Full text

Life Sciences, Endocrinology, Pharmacotherapy +16

Excellent response to pasireotide therapy in an aggressive and dopamine-resistant prolactinoma

Eva C Coopmans, Sebastiaan W F van Meyel, Kay Pieterman et al. · European Journal of Endocrinology · 2019 · 59 citations · Full text

Medicine, Endocrinology, Oncology +14

Efficacy and safety of switching to pasireotide in acromegaly patients controlled with pegvisomant and somatostatin analogues: PAPE extension study

Ammar Muhammad, Eva C Coopmans, Patric J. D. Delhanty et al. · European Journal of Endocrinology · 2018 · 57 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +14